Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
303.53
-4.29 (-1.39%)
At close: Oct 23, 2026, 4:00 PM EDT
303.53
0.00 (0.00%)
After-hours: Oct 23, 2026, 5:09 PM EDT
Ligand Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $388 → $406 | Buy | Reiterates | $388 → $406 | +33.76% | Oct 19, 2026 |
| Barclays | Barclays | Buy Initiates $345 | Buy | Initiates | $345 | +13.66% | Sep 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $358 | Buy | Maintains | $358 | +17.95% | Sep 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 23, 2026 |
| Citi | Citi | Buy Maintains $390 → $397 | Buy | Maintains | $390 → $397 | +30.79% | Sep 23, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 23, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $345 | Buy | Reiterates | $345 | +13.66% | Aug 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $326 | Buy | Reiterates | $326 | +7.40% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.